The immunopathology of sepsis and potential therapeutic targets
- PMID: 28436424
- DOI: 10.1038/nri.2017.36
The immunopathology of sepsis and potential therapeutic targets
Abstract
Sepsis is defined as a life-threatening organ dysfunction that is caused by a dysregulated host response to infection. In sepsis, the immune response that is initiated by an invading pathogen fails to return to homeostasis, thus culminating in a pathological syndrome that is characterized by sustained excessive inflammation and immune suppression. Our understanding of the key mechanisms involved in the pathogenesis of sepsis has increased tremendously, yet this still needs to be translated into novel targeted therapeutic strategies. Pivotal for the clinical development of new sepsis therapies is the selection of patients on the basis of biomarkers and/or functional defects that provide specific insights into the expression or activity of the therapeutic target.
Comment in
-
Are histones real pathogenic agents in sepsis?Nat Rev Immunol. 2018 Feb;18(2):148. doi: 10.1038/nri.2017.156. Epub 2017 Dec 27. Nat Rev Immunol. 2018. PMID: 29279612 No abstract available.
-
Are histones real pathogenic agents in sepsis?Nat Rev Immunol. 2018 Feb;18(2):148. doi: 10.1038/nri.2017.157. Epub 2017 Dec 27. Nat Rev Immunol. 2018. PMID: 29279614 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical